Citigroup
BBP icon

Citigroup’s Virtus Biotech ETF BBP Stock Holding History

Citigroup’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$83 – 5736
2026
Q1 		$83 Buy
+1
New +$82 ﹤0.01% 5617
2016
Q1 		– Sell
-41
Closed -$1K – 7450
2015
Q4 		$1K Buy
41
+35
+583% +$1.06K ﹤0.01% 7356
2015
Q3 		$0 Buy
+6
New +$202 ﹤0.01% 7371

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup's BBP Position: Q2 2026 in Review

Citigroup sold out of Virtus Biotech ETF (BBP) in Q2 2026, closing a stake of 1 share — an estimated $83 sold.

Citigroup first reported a position in BBP in Q3 2015 and held it in 3 quarters. The position peaked at $1K in Q4 2015. 25 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • Citigroup reported no remaining Virtus Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 1 Virtus Biotech ETF share in Q2 2026, an estimated $83.
  • Citigroup first reported a position in Virtus Biotech ETF in Q3 2015 and held it in 3 quarters.
  • Citigroup's Virtus Biotech ETF position peaked at $1K in Q4 2015.
  • 25 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.